We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

587 hedge funds and large institutions have $9.76B invested in Varian Medical Systems, Inc. in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 167 increasing their positions, 235 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $9.63M | Put options by funds: $7.2M

15% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 47

1% more funds holding

Funds holding: 584587 (+3)

8% less capital invested

Capital invested by funds: $10.6B → $9.76B (-$810M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

29% less repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 235

Holders
587
Holders Change
+3
Holders Change %
+0.51%
% of All Funds
13.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
54
Increased
167
Reduced
235
Closed
47
Calls
$9.63M
Puts
$7.2M
Net Calls
+$2.43M
Net Calls Change
+$27.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
276
Creative Planning
Kansas
$1.15M -$120 -1 -0%
MME
277
Meag Munich Ergo
Germany
$1.14M -$543K -4,534 -31%
OAM
278
Oppenheimer Asset Management
New York
$1.14M -$283K -2,367 -19%
CIBC Asset Management
279
CIBC Asset Management
Ontario, Canada
$1.14M -$377K -3,153 -24%
V
280
Veritable
Delaware
$1.13M
SAM
281
Smithbridge Asset Management
Pennsylvania
$1.11M
COPPSERS
282
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.09M +$169K +1,409 +17%
CA
283
Commerzbank Aktiengesellschaft
Germany
$1.08M +$29.4K +246 +3%
WG
284
Winton Group
United Kingdom
$1.06M -$5.51M -46,074 -83%
SAM
285
Securian Asset Management
Minnesota
$1.06M +$13.8K +115 +1%
BA
286
Bridgewater Associates
Connecticut
$1.03M +$848K +7,090 +360%
NAM
287
Nissay Asset Management
Japan
$1.02M -$31.6K -264 -3%
EHC
288
Everett Harris & Co
California
$980K -$8.97K -75 -0.9%
CS
289
Candriam SCA
Luxembourg
$958K -$3.39M -28,322 -77%
FT
290
Fiduciary Trust
Massachusetts
$957K
NMERB
291
New Mexico Educational Retirement Board
New Mexico
$955K -$35.9K -300 -3%
GT
292
Glenview Trust
Kentucky
$946K
CCFCSB
293
Cape Cod Five Cents Savings Bank
Massachusetts
$945K -$15.3K -128 -2%
SRC
294
Stone Run Capital
New York
$925K
ECM
295
Element Capital Management
New York
$923K +$476K +3,982 +96%
EHWM
296
Eads & Heald Wealth Management
Georgia
$921K -$41.9K -350 -4%
SRAM
297
Stone Ridge Asset Management
New York
$917K +$173K +1,442 +22%
SNT
298
Security National Trust
West Virginia
$910K
Baird Financial Group
299
Baird Financial Group
Wisconsin
$908K -$2.51K -21 -0.3%
GXMC
300
Global X Management Company
New York
$890K -$169K -1,409 -15%

VAR Hedge Fund Activity: Q2 2018 in Review

587 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q2 2018, worth a combined $9.76B — down 7.7% from $10.6B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new VAR positions and 47 closed out — a net gain of 7 holders — while 167 added to existing stakes and 235 trimmed.

The largest buyer was Jupiter Investment Management, adding an estimated $109M. The largest seller was First Eagle Investment Management, cutting an estimated $118M.

  • 587 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q2 2018, up from 584 in Q1 2018.
  • Funds reported $9.76B of Varian Medical Systems, Inc. stock for Q2 2018, down 7.7% quarter-over-quarter.
  • 54 funds opened new Varian Medical Systems, Inc. positions in Q2 2018 and 47 closed out, a net change of +7 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q2 2018 was Jupiter Investment Management, an estimated $109M added.
  • The largest Varian Medical Systems, Inc. seller in Q2 2018 was First Eagle Investment Management, an estimated $118M sold.

Based on aggregated 13F filings for Q2 2018.